José A. Obeso Inchausti-rekin lankidetzan egindako argitalpenak (12)

2024

  1. Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson’s disease model

    npj Parkinson's Disease, Vol. 10, Núm. 1

2015

  1. Editorial: Parkinson’s disease: Cell vulnerability and disease progression

    Frontiers in Neuroanatomy

2012

  1. Functional neuroanatomy of the basal ganglia

    Cold Spring Harbor Perspectives in Medicine, Vol. 2, Núm. 12

2011

  1. Past, present, and future of the pathophysiological model of the basal ganglia

    Frontiers in Neuroanatomy

2010

  1. A direct projection from the subthalamic nucleus to the ventral thalamus in monkeys

    Neurobiology of Disease, Vol. 39, Núm. 3, pp. 381-392

2008

  1. Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys

    Movement Disorders, Vol. 23, Núm. 5, pp. 708-715

2005

  1. Thalamic innervation of the direct and indirect basal ganglia pathways in the rat: Ipsi- and contralateral projections

    Journal of Comparative Neurology, Vol. 483, Núm. 2, pp. 143-153

2004

  1. How does Parkinson's disease begin? The role of compensatory mechanisms (multiple letters)

    Trends in Neurosciences

  2. Thalamic innervation of striatal and subthalamic neurons projecting to the rat entopeduncular nucleus

    European Journal of Neuroscience, Vol. 19, Núm. 5, pp. 1267-1277

  3. The origin of motor fluctuations in Parkinson's disease: Importance of dopaminergic innervation and basal ganglia circuits

    Neurology, Vol. 62, Núm. 1 SUPPL. 1

2002

  1. The parafascicular thalamic complex and basal ganglia circuitry: Further complexity to the basal ganglia model

    Thalamus and Related Systems, Vol. 1, Núm. 4, pp. 341-348

2000

  1. Pathophysiology of the basal ganglia in Parkinson's disease

    Trends in Neurosciences, Vol. 23, Núm. 10 SUPPL.